Skip to main content
Top
Published in: BMC Neurology 1/2021

Open Access 01-12-2021 | Hypotension | Research article

Controlled arterial hypotension during resection of cerebral arteriovenous malformations

Authors: Katharina Riedel, Marcus Thudium, Azize Boström, Johannes Schramm, Martin Soehle

Published in: BMC Neurology | Issue 1/2021

Login to get access

Abstract

Background

Resection of cerebral arteriovenous malformations (AVM) is technically demanding because of size, eloquent location or diffuse nidus. Controlled arterial hypotension (CAH) could facilitate haemostasis. We performed a study to characterize the duration and degree of CAH and to investigate its association with blood loss and outcome.

Methods

We retrospectively analysed intraoperative arterial blood pressure of 56 patients that underwent AVM-resection performed by the same neurosurgeon between 2003 and 2012. Degree of CAH, AVM size, grading and neurological outcome were studied. Patients were divided into two groups, depending on whether CAH was performed (hypotension group) or not (control group).

Results

The hypotension group consisted of 28 patients, which presented with riskier to treat AVMs and a higher Spetzler-Martin grading. CAH was achieved by application of urapidil, increasing anaesthetic depth or a combination thereof. Systolic and mean arterial blood pressure were lowered to 82 ± 7 and 57 ± 7 mmHg, respectively, for a median duration of 58 min [25% percentile: 26 min.; 75% percentile: 107 min]. In the hypotension group, duration of surgery (4.4 ± 1.3 h) was significantly (p <  0.001) longer, and median blood loss (500 ml) was significantly (p = 0.002) higher than in the control group (3.3 ± 0.9 h and 200 ml, respectively). No case fatalities occurred. CAH was associated with a higher amount of postoperative neurological deficits.

Conclusions

Whether CAH caused neurological deficits or prevented worse outcomes could be clarified by a prospective randomised study, which is regarded as ethically problematic in the context of bleeding. CAH should only be used after strict indication and should be applied as mild and short as possible.
Literature
10.
go back to reference Erickson KM, Cole DJ. Arterial hypotension and hypertension during neurosurgical procedures. In: Brambrink AM, Kirsch JR, editors. Essentials of neurosurgical anesthesia & critical care. New York: Springer; 2012. p. 363–70.CrossRef Erickson KM, Cole DJ. Arterial hypotension and hypertension during neurosurgical procedures. In: Brambrink AM, Kirsch JR, editors. Essentials of neurosurgical anesthesia & critical care. New York: Springer; 2012. p. 363–70.CrossRef
12.
go back to reference Flemming KD, Brown RD. The natural history of intracranial arteriovenous malformations. In: Winn HR, editor. Youmans neurological surgery. 6th ed. Philadelphia: Elsevier Saunders; 2011. p. 4016–33.CrossRef Flemming KD, Brown RD. The natural history of intracranial arteriovenous malformations. In: Winn HR, editor. Youmans neurological surgery. 6th ed. Philadelphia: Elsevier Saunders; 2011. p. 4016–33.CrossRef
19.
go back to reference Lam AM, Gelb AW. Cardiovascular effects of isoflurane-induced hypotension for cerebral aneurysm surgery. Anesth Analg. 1983;62:742–8.CrossRef Lam AM, Gelb AW. Cardiovascular effects of isoflurane-induced hypotension for cerebral aneurysm surgery. Anesth Analg. 1983;62:742–8.CrossRef
20.
go back to reference Lawton MT. Intraoperative arteriovenous malformation rupture. Thieme: Seven AVMs: Tenets and techniques for resection; 2014. p. 36–8. Lawton MT. Intraoperative arteriovenous malformation rupture. Thieme: Seven AVMs: Tenets and techniques for resection; 2014. p. 36–8.
25.
go back to reference Mohr JP, Overbey JR, Hartmann A, Kummer RV, Al-Shahi Salman R, Kim H, et al. Medical management with interventional therapy versus medical management alone for unruptured brain arteriovenous malformations (ARUBA): final follow-up of a multicentre, non-blinded, randomised controlled trial. Lancet Neurol. 2020;19:573–81. https://doi.org/10.1016/S1474-4422(20)30181-2.CrossRefPubMed Mohr JP, Overbey JR, Hartmann A, Kummer RV, Al-Shahi Salman R, Kim H, et al. Medical management with interventional therapy versus medical management alone for unruptured brain arteriovenous malformations (ARUBA): final follow-up of a multicentre, non-blinded, randomised controlled trial. Lancet Neurol. 2020;19:573–81. https://​doi.​org/​10.​1016/​S1474-4422(20)30181-2.CrossRefPubMed
33.
go back to reference Soehle M. Cerebral ischemia: options for perioperative neuroprotection. In: Brambrink AM, Kirsch JR, editors. Essentials of neurosurgical anesthesia & critical care. New York: Springer; 2012. p. 175–84.CrossRef Soehle M. Cerebral ischemia: options for perioperative neuroprotection. In: Brambrink AM, Kirsch JR, editors. Essentials of neurosurgical anesthesia & critical care. New York: Springer; 2012. p. 175–84.CrossRef
37.
go back to reference Steiger HJ, Fischer I, Rohn B, Turowski B, Etminan N, Hanggi D. Microsurgical resection of Spetzler-Martin grades 1 and 2 unruptured brain arteriovenous malformations results in lower long-term morbidity and loss of quality-adjusted life-years (QALY) than conservative management--results of a single group series. Acta Neurochir. 2015;157:1279–87. https://doi.org/10.1007/s00701-015-2474-9.CrossRefPubMed Steiger HJ, Fischer I, Rohn B, Turowski B, Etminan N, Hanggi D. Microsurgical resection of Spetzler-Martin grades 1 and 2 unruptured brain arteriovenous malformations results in lower long-term morbidity and loss of quality-adjusted life-years (QALY) than conservative management--results of a single group series. Acta Neurochir. 2015;157:1279–87. https://​doi.​org/​10.​1007/​s00701-015-2474-9.CrossRefPubMed
42.
go back to reference Young WL, Kader A, Ornstein E, Baker KZ, Ostapkovich N, Pile-Spellman J, et al. Cerebral hyperemia after arteriovenous malformation resection is related to “breakthrough” complications but not to feeding artery pressure. The Columbia University Arteriovenous Malformation Study Project. Neurosurgery. 1996;38:1085–93; discussion 1093-1085. https://doi.org/10.1097/00006123-199606000-00005.CrossRefPubMed Young WL, Kader A, Ornstein E, Baker KZ, Ostapkovich N, Pile-Spellman J, et al. Cerebral hyperemia after arteriovenous malformation resection is related to “breakthrough” complications but not to feeding artery pressure. The Columbia University Arteriovenous Malformation Study Project. Neurosurgery. 1996;38:1085–93; discussion 1093-1085. https://​doi.​org/​10.​1097/​00006123-199606000-00005.CrossRefPubMed
43.
go back to reference Zäll S, Edén E, Winsö I, Volkmann R, Sollevi A, Ricksten SE. Controlled hypotension with adenosine or sodium nitroprusside during cerebral aneurysm surgery: effects on renal hemodynamics, excretory function, and renin release. Anesth Analg. 1990;71:631–6.PubMed Zäll S, Edén E, Winsö I, Volkmann R, Sollevi A, Ricksten SE. Controlled hypotension with adenosine or sodium nitroprusside during cerebral aneurysm surgery: effects on renal hemodynamics, excretory function, and renin release. Anesth Analg. 1990;71:631–6.PubMed
Metadata
Title
Controlled arterial hypotension during resection of cerebral arteriovenous malformations
Authors
Katharina Riedel
Marcus Thudium
Azize Boström
Johannes Schramm
Martin Soehle
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2021
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-021-02362-x

Other articles of this Issue 1/2021

BMC Neurology 1/2021 Go to the issue